Endovascular Aortic Aneurysm Repair in Patients with Aortoiliac Occlusive Disease by Mangum, Kevin D. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Endovascular Aortic Aneurysm 
Repair in Patients with Aortoiliac 
Occlusive Disease
Kevin D. Mangum, Arash Fereydooni and Naiem Nassiri
Abstract
Although endovascular aortic aneurysm repair (EVAR) has become an attrac-
tive, minimally invasive option for patients with abdominal aortic aneurysms 
(AAA), significant challenges in arterial access exist in patients with concomitant 
aortoiliac occlusive disease (AIOD), particularly for more advanced TASC C and 
D lesions. Under these circumstances, endograft delivery is possible but requires 
extensive preoperative planning and intraoperative techniques including but not 
limited to surgical conduit creation, plain balloon angioplasty, endoconduit place-
ment, and subintimal recanalization. Newer generation aortic endografts have also 
shown promise in accommodating compromised access vessels. Concomitant AIOD 
and compromised access vessels complicate EVAR and increase operative time 
and complexity. Therefore, extreme caution, meticulous preoperative planning, 
familiarity and facility with the various surgical and endovascular options needed 
to circumvent these obstacles are essential for safe and effective delivery of EVAR in 
this high-risk subset of patients. The purpose of this chapter is to present standard 
approaches for access in patients undergoing EVAR; discuss how advanced AIOD 
precludes routine access; and present various methods to overcome difficult access 
in patients undergoing EVAR.
Keywords: abdominal aortic aneurysm, endovascular aortic aneurysm repair, 
aortoiliac occlusive disease, endograft, aorta, iliac artery, femoral artery, access, 
endoconduit
1. Introduction
Endovascular aortic aneurysm repair (EVAR) has expanded to more than 75% 
of elective abdominal aortic aneurysm (AAA) repairs due to its lower perioperative 
complication and high technical success rate [1, 2]. Despite its advantages, however, 
there are specific limitations that preclude EVAR delivery, making open AAA 
repair a more suitable option for select patients. In general, patient age and overall 
health are important considerations in deciding between EVAR versus open repair. 
Anatomic factors may also limit use of EVAR in select patients, and one of the single 
most important of these is proximal neck anatomy [3]. Unsuitable, hostile proximal 
neck features include angulation of ≥60°, neck length ≤ 10 mm, focal bulge in the 
neck >3 mm, and thrombus involving ≥50% of the aortic diameter—all common 
EVAR limiting factors [4]. In addition, access related issues due to atherosclerotic 
occlusive disease remain major barriers to EVAR as up to 36% of patients with AAA 
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suffer from some degree of aortoiliac occlusive disease (AIOD) [5]. Concomitant 
AIOD may preclude EVAR in 6–15.4% of patients [6, 7]. The current Trans-Atlantic 
Inter-Society Consensus (TASC) guidelines consider an aneurysm in combination 
with a significant iliac artery stenosis or occlusion a TASC D lesion, and open surgi-
cal repair is suggested for these patients [8]. However, open repair is still associated 
with an in-hospital mortality rate of approximately 4%, particularly in this high-
risk subset of patients with significant comorbidities that are associated with their 
peripheral arterial disease [9]. This combination of factors makes patients with 
AAA and AIOD even higher-risk candidates for open surgery.
Within the subset of patients with AAA and concomitant AIOD, about 15% 
require adjunctive access-related procedures to facilitate EVAR [10]. Furthermore, 
previously stented iliofemoral vessels are increasingly encountered and pose 
significant technical challenges for endovascular access and EVAR limb durability 
[11]. Overall, access-related complications—such as dissection and rupture—at the 
time of EVAR approach 10% compared to 15% in patients with concomitant AIOD 
[12]. Even though there has been a general reduction in device size in recent years 
compared with older generation aortic endoprostheses, some of the commonly used 
devices and most branched and fenestrated repair endovascular systems continue 
to require larger-diameter sheaths and delivery conduits. There are currently 
no clinical guidelines delineating the optimal therapy in patients with AAA and 
concomitant AIOD. Thus, familiarity with various techniques that can overcome 
compromised access vessels is essential for the modern-day vascular surgeon. These 
techniques have been developed to circumvent previously prohibitive anatomy and 
are discussed in this chapter. The emphasis herein will be on less invasive endovascu-
lar means of facilitating access in patients with compromised aortoiliac anatomy in 
the setting of AAA.
2. Access
2.1 Surgical access
The common femoral artery (CFA) is the most commonly accessed site for 
EVAR and has traditionally been approached via surgical cutdown. Typically, an 
incision is made parallel to and approximately two-finger breadths inferior to the 
inguinal ligament at the midway point between the anterior superior iliac spine and 
the pubic symphysis overlying the femoral pulse if palpable [13]. The superficial 
femoral fascia (contiguous with Scarpa’s fascia) is divided obliquely, while the deep 
femoral fascia is divided parallel to femoral artery.
In cases of severely diseased or occluded CFAs, focal endarterectomy with patch 
angioplasty may be necessary prior to or immediately after EVAR to avoid limb-
threatening ischemia and to facilitate EVAR delivery. Longitudinal skin incisions 
extending inferiorly from the inguinal ligament distally to the femoral bifurcation 
are preferred under these circumstances to facilitate adequate endarterectomy with 
profundaplasty if necessary. The proximal superficial femoral artery (SFA)—if 
patent and relatively disease-free—might be another option for access in cases of 
compromised CFAs or hostile groins. In such cases, the SFA is accessed via direct 
surgical cutdown along the medial border of the sartorius muscle [14].
2.2 Percutaneous access
Percutaneous access for EVAR was initially described in 1999, when the Prostar 
XL device (Abbot Vascular, Abbott Park, IL) was used for suture-mediated closure 
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of femoral arteries [15]. The device is indicated for closure of vessels after percu-
taneous access of up to 10 Fr. If required, multiple devices can be used for larger 
caliber access closure [16].
The more popular Perclose ProGlide device (Abbot Vascular, Abbott Park, IL) is 
indicated for femoral access closure of up to 8 Fr for each closure device. It differs 
from the Prostar XL device in that it uses a single monofilament polypropylene 
suture instead of two braided polyester sutures. Multiple Perclose devices can be 
used to achieve closure for larger caliber arteriotomies up to 24 Fr inner diameter. 
This is achieved by deploying Perclose devices 45° clockwise and counterclockwise 
relative to the initially deployed device at the 12 o’clock position [17]. If needed, 
additional Perclose devices can be deployed for adequate hemostasis as long as wire 
access is maintained throughout the serial deployment process.
A recent meta-analysis of outcomes of percutaneous EVAR showed a technical 
success rate (defined as freedom from additional perioperative procedures) of 93%. 
There was an increased risk of conversion to cutdown when using sheaths ≥20 Fr [18]. 
Notably, both severe or anterior common femoral calcification and small access vessel 
diameter (<5 mm) have been associated with failed percutaneous access [18, 19]. In 
our own experience, we have found extreme iliac vessel tortuosity to be another pre-
dictor of unsuccessful percutaneous EVAR, given difficulty in closure device tracking 
and proper deployment of the footplate. To date, there has been no appropriately pow-
ered prospective, randomized study comparing percutaneous suture-mediated closure 
devices to open cutdown in EVAR. For now, a higher threshold for a total percutaneous 
approach and a readily available conversion mechanism to open surgical cutdown is 
advisable, particularly if one or more anatomically limiting factors are present.
3. Challenging access
3.1 Predicting access difficulty
In order to prevent inadvertent arterial injury and to avoid emergent measures, 
evaluation of the caliber and disease burden of all access vessels should be per-
formed preoperatively based on adequate contrast-enhanced imaging. While com-
puted tomography angiography (CTA) remains the preoperative imaging modality 
of choice, compromised access vessels may require catheter-directed angiography 
for pre-operative evaluation and/or treatment of access-related disease in anticipa-
tion of EVAR and for more appropriate device selection. The latter should be, in 
part, based on access vessel considerations such as patency, diameter, tortuosity, 
and severity of calcification. This is particularly important in older patients who 
have calcified, minimally elastic vessels and cannot tolerate excessive oversizing or 
stretching of the access vessels [20]. The minimum access vessel diameter require-
ment varies considerably based on the EVAR device manufacturer and the instruc-
tions for use (IFUs) for each particular device. A list of some of the commonly used 
endografts and their required iliac artery diameter has been provided in Table 1.
3.2 Conduit selection
Choice of conduit for EVAR delivery in the setting of AIOD is based on indi-
vidual anatomy and disease severity. In general, TASC A and B disease may be 
amenable to simple balloon angioplasty of stenotic iliac arteries, after which the 
aortic endograft and/or required delivery sheath can be advanced. We caution 
against repeat balloon angioplasty and the use of oversized balloons due to associ-
ated life-threatening rupture that may result. In situations where simple angioplasty 
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does not seem to accommodate EVAR delivery, we recommend prophylactic covered 
stent placement prior to more aggressive angioplasty and the disruption of native 
vessel plaque. This technique provides a control mechanism if rupture occurs 
during angioplasty. For angioplasty alone, balloon diameter should not exceed the 
native vessel adventitia-to-adventitia diameter. Meticulous maintenance of guide 
wire access as well as immediately available balloon occlusion catheters and appro-
priately sized covered stents are strongly recommended at the time of angioplasty.
More advanced TASC C & D lesions often require a more comprehensive 
planning for safe and effective EVAR delivery. While open aortic surgery remains 




Access (outer) diameter 
(mm)
Abdominal aortic endograft
Zenith Flex (Cook) 22–26 18 7.1
28–32 20 7.7
36 22 8.5
Excluder (Gore) 23–28 18 7.0
31 20 7.6
Endurant II (Medtronic) 23–28 18* 7
32–36 20* 7.6
AFX (Endologix) 22–28 17 6.5
Ovation (Endologix) 20–29 14 4.5
34 15 4.5
Nellix (Endologix) 18–28 17 7
Thoracic aortic endograft
Zenith Alpha (Cook) 24–30 16 6
32–38 18 7.1
40–44 20 7.7














List of current abdominal and thoracic aortic endografts and their size specifications. *Represents outer 
diameter (OD) measurement (not sheath size) for Medtronic devices.
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a consideration in these patients, high risk candidates warrant consideration for 
creative and less invasive endovascular approaches [21].
3.3 Surgical conduits
Open surgical conduits provide the advantage of larger conduits for device 
delivery and surgically exposed access for repair of any inadvertent arterial injury. 
Most surgical conduits are created at the distal common or proximal external iliac 
artery (EIA) using a lower retroperitoneal incision. The ideal strategy depends 
on the status of the iliac arteries (e.g., calcification and patency of internal iliac 
arteries) and the surgical risk for each individual patient. Most patients can toler-
ate a retroperitoneal exposure. However, this is a less ideal option in patients with 
hostile anatomy, prior surgery or radiation, retroperitoneal fibrosis, or in those 
with extensive comorbidities [20]. Standard surgical precautions should be taken to 
avoid ureteral injury and sympathetic plexus injury on the left side in men. Despite 
their advantages, however, surgical conduits should be used judiciously, given their 
reported association with longer operative times, hernias, prosthetic remnant infec-
tion, and prolonged recovery [22].
Although the common iliac artery (CIA) can be directly accessed with a sheath, 
a conduit often simplifies the procedure and provides increased availability of the 
iliac landing zone for EVAR. In creating the conduit, first the iliac arteries are con-
trolled, and then a longitudinal arteriotomy is made anteriorly extending from the 
distal common to the external iliac artery [20]. A 10-mm Dacron graft is spatulated 
and anastomosed end-to-side to the native vessel. Of note, Fogarty occlusion bal-
loon is a useful adjunct for vessel control in cases where severe calcification of the 
iliac arteries precludes safe and adequate surgical clamping [20].
A stab incision can be performed in the lower abdominal wall to exteriorize 
the conduit [23]. If there is severe external iliac occlusive disease, the conduit can 
be tunneled under the inguinal ligament to a counter incision in the groin to be 
converted to an iliofemoral bypass at the completion of the case [14]. This maneu-
ver is also suitable for cases with planned repeat interventions in the future. Access 
is established via direct graft puncture after clamping and stabilizing the external-
ized distal end of the graft. Upon completion of the procedure, the conduit can be 
ligated and oversewn near the anastomosis leaving a short stump.
In cases with anticipated prolonged lower extremity ischemia time and patients 
with severe aortoiliac and profunda femoral disease, a temporary femoral artery 
conduit can be used to minimize lower extremity ischemia—reperfusion. A 10-mm 
femoral conduit is anastomosed end-to-side to the CFA using a standard oblique 
or longitudinal groin incision. The conduit allows periodic withdrawal of occlusive 
sheaths with restoration of flow while maintaining guide-wire access [20].
In cases with planned staged interventions for extensive thoracoabdominal 
repairs, permanent iliofemoral conduits are better options to avoid redo retroperito-
neal exposure. Depending on patient anatomy and the extent of iliofemoral disease, 
there are several possible configurations. Iliofemoral bypass can be created from the 
distal CIA or proximal EIA to the proximal CFA, with access established into the 
graft after flow is restored to lower extremity [20].
Although direct iliac exposure might allow for better control of iliac injury, it is 
not without complications. In a study of 15,082 patients who underwent infrarenal 
EVAR from 2005 to 2012, 147 (1%) required iliac conduit or direct iliac access 
and had a higher rate of long-term mortality. [24] Compared to standard bilateral 
femoral exposure, surgical conduits also have a 1.8-fold increase in perioperative 
complications and a 1.5-day increase in length of hospital stay, but have no statisti-
cally significant difference in early mortality [25]. Furthermore, compared to 
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percutaneous access, iliac exposure is associated with increased overall morbidity, 
operative time, intraoperative transfusion, and length of stay [14].
3.4 Alternative adjunctive techniques
Yano et al. reported that 50 of 390 patients (12%) undergoing EVAR required 
adjunctive maneuvers for endograft delivery [10]. Several adjunctive maneuvers have 
been proposed for patients with compromised and/or tortuous iliac arteries to facilitate 
EVAR [26]. Infrainguinal mobilization and “pull-down” of redundant external iliac 
arteries as well as lower abdominal manual compression during device advancement 
have been reported [20]. Alternatively, snared brachial-femoral wire access allows for a 
“body-floss” effect to stabilize the advancement of the delivery system through acutely 
angulated, redundant iliac arteries [27, 28]. For the brachial-femoral technique, it is 
useful to have an extended shaft brachial sheath to prevent the wire from transecting 
the subclavian-aortic junction or other angulated arterial segments [22].
Serial dilatation of the iliac artery with rigid dilators can be attempted, but 
application of excessive force should be avoided. Using this approach, an endovascu-
lar dilator set (Cook Medical, Bloomington, Indiana) consisting of dilators ranging 
from 14 to 26 Fr may be used to gradually dilate narrow, diseased iliac arteries [29]. 
Alternatively, a Solopath (Terumo, Somerset, NJ) balloon-expandable sheath can 
also be used in select cases where tortuosity and plaque is the main limiting factor 
[20]. The malleable design and hydrophilic coating of the sheath enable smooth 
tracking through narrowed vessels while the expandable balloon dilates stenosis [30].
3.5 Endoconduits
Increased morbidity with surgical conduits has led to the development of endovas-
cular measures that facilitate EVAR in the setting of compromised access vessels [31]. 
Stents or stent-grafts are used to dilate atretic iliac arteries, correct any underlying 
occlusive disease, and/or over-dilate the artery beyond its baseline-limited caliber. 
First described in a series of five patients in 2001, this technique involved sewing a 
6-mm expanded polytetrafluoroethylene graft to a stent and backloading the device 
into a 6F sheath [10]. The stent portion of the device was deployed across the inter-
nal iliac artery (IIA) and the prosthetic portion across the external iliac artery. The 
prosthetic portion was exteriorized through the femoral artery, and a noncompliant 
balloon was used to dilate the external iliac artery from within the graft.
Later in 2007, the “pave and crack” technique was introduced. Common and 
external iliac arteries were lined with 10-mm balloon expandable or self-expanding 
stents, and the stents were then dilated to 9–12 mm to create a controlled rupture 
[32]. In a similar technique, a 12-mm Excluder contralateral iliac limb (Gore, 
Flagstaff, AZ) was deployed from the common iliac extending into the proximal 
common femoral artery [33]. For this technique, it has been recommended to dilate 
the endoconduit to approximately 2 mm larger than the outer diameter of the 
intended endoprosthesis to allow for successful device delivery.
When planned and performed properly, endovascular conduits can be less inva-
sive and have shorter procedural and recovery times compared to surgical conduits. 
Risks—such as stent dislodgement, coverage of internal iliac artery, and rupture—can 
be largely avoided with a measured, planned approach; appropriate device selection 
based on anatomic considerations; as well as familiarity with the nuances of the cho-
sen EVAR device, its specific IFUs, and delivery apparatus. At times, a staged approach 
to endoconduit delivery—comprised of iliofemoral revascularization using covered 
stents with or without concomitant femoral endarterectomy followed by EVAR at a 
later date—may be necessary. The staged approach allows for stent incorporation, 
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minimizing the risk of stent dislodgement, and development of collateral network 
in cases of intentional branch vessel occlusion. Furthermore, bifurcated unibody 
endografts or aorto-uni-iliac stent grafts may be chosen to overcome certain anatomic 
configurations; the former is particularly useful in the setting of a diseased, narrow 
distal aortic domain and may be the best option for avoidance of iliac limb occlusion.
Our covered stent of choice for endoconduit creation is the Viabahn stent-
graft (Gore, Flagstaff, AZ). This technique was first described in 2009 using a 
13 mm × 10 cm Viabahn dilated to 12 mm and an 8 mm × 5 cm Viabahn dilated to 
8 mm [34, 35]. If the common iliac artery is larger than 13 mm, a tapered 16–12 mm 
Excluder iliac limb (Gore, Flagstaff, AZ) can be used [20]. More recently, the Gore 
VBX balloon-expandable covered stent system has been introduced [36]. The L con-
figuration of this stent graft allows for post-dilation of up to 16-mm diameter. It has 
become our stent graft of choice for more aggressive post-dilation of compromised 
iliac arteries. In general, balloon expandable covered stents are used proximally in 
less mobile ostial locations, while flexible self-expanding covered stents are better 
choices distally in the external iliac arteries and more tortuous vessels due to their 
greater flexibility (Figures 1 and 2).
Figure 1. 
(A) Diffusely diseased bilateral common and external iliac arteries precluding device advancement. (B, C) 
Endoconduits were created bilaterally with proximal VBX balloon expandable covered stents (Gore, Flagstaff, AZ), 
followed distally by self-expanding Viabahns (Gore, Flagstaff, AZ) extending into the proximal CFAs bilaterally. 
(C) Note the preserved patency of the right IIA. Post deployment angioplasty was performed with oversized 
balloons to facilitate easy (D) advancement and (E) deployment of an Endurant II aortic endograft (Medtronic, 
Minneapolis, Minnesota) and associated iliac limbs. (F) Completion angiogram demonstrated complete exclusion of 
the aneurysm sac without endoleak and unimpeded flow through the newly revascularized bilateral iliac arteries.
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Figure 2. 
(A) Three-dimensional reconstruction of the pre-operative CTA showing a juxtarenal abdominal aortic 
aneurysm with severe calcified stenosis of the bilateral common and external iliac arteries and occluded distal 
bilateral internal iliac arteries. (B) Flush abdominal aortography with bilateral iliofemoral runoff delineates 
shape and configuration of the aneurysm and confirms (C, D) the bilateral iliac disease burden. (E, F) 
Endoconduits were created using VBX balloon-expandable and Viabahn self-expanding covered stents (Gore, 
Flagstaff, AZ) bilaterally. The former are placed in the more proximal aspects of the diseased iliac arteries, 
while the latter are placed in the more mobile distal aspects of the iliac arteries to better accommodate hip 
flexion. Post-deployment angioplasty is an essential maneuver to ensure adequate endoconduit lumen diameter 
for advancing the device and to minimize risk of stent dislodgement during endograft delivery (G). Completion 
angiogram demonstrated complete exclusion of the AAA and a widely patent aortic endograft, CIAs, EIAs and 
left IIA without endoleak or kinks.
For advanced occlusive iliac lesions, covered stents are preferred over bare metal 
stents (BMS). The seminal COBEST study demonstrated that covered and BMS pro-
duced similar results for TASC B lesions; while for TASC C and D disease, covered 
stents had better long-term patency rates and lower reintervention rates [37]. Other 
advantages of covered stents over BMS include minimized in-stent neointimal 
hyperplasia and decreased risk of arterial perforation [38].
3.6 Angioplasty
Plain balloon angioplasty is favored as first-line strategy for low TASC-grade 
stenotic disease. We generally use 7–8-mm ultra-noncompliant balloons for passage 
of sheaths up to 18 Fr; 10-mm balloons for sheaths up to 22 Fr; and 12-mm balloons 
for 24 Fr sheaths.
When delivering devices that are not preloaded in sheaths, passage of the 
sheath dilator alone as the next step after ultra-noncompliant angioplasty of iliac 
occlusive disease is recommended [14]. The diameter of the dilator should be equal 
to or greater than the diameter of the anticipated endograft delivery mechanism. 
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Following this initial dilator passage step, the sheath and dilator are advanced 
together into the distal aorta. If the sheath meets obstruction, it is left in place, the 
dilator is removed, and the endograft is advanced “bareback” for the remaining 
length. Overdilating uncovered diseased or normal vessels to overcome a basic size 
mismatch is strongly discouraged due to risk of rupture. In such situations, endo-
conduits are better options, as they permit adequate angioplasty without risking 
iliac artery rupture in an uncontrolled fashion [10, 39]. When adequate distal and 
proximal seal is achieved via endoconduit creation, more aggressive angioplasty can 
be performed with lower risk for catastrophic hemorrhage [33].
3.7 Intraluminal or subintimal recanalization
Historically, in cases of severely diseased or occluded unilateral iliac arteries, 
aorto-uni-iliac stent-graft deployment with femoral-femoral bypass is performed 
[40, 41]. However, randomized trials have demonstrated approximately 20% lower 
long-term patency for femoral-femoral bypass compared to endovascular recon-
struction in cases of unilateral iliac occlusive disease [42]. For EVAR, the aorto-
uni-iliac configuration is also associated with inferior early and midterm outcomes 
as well as increased risk of graft infection [43, 44]. Therefore, in appropriately 
selected elective cases, intraluminal or subintimal recanalization from either 
brachial or femoral approach can be considered as alternative means of facilitating 
bifurcated EVAR device delivery [21]. Of note, successful subintimal recanalization 
has been described to facilitate bifurcated endograft placement in the presence of 
bilateral common iliac occlusive disease, making it an appropriate EVAR delivery 
method in select patients [14].
3.8 New generation of aortic endografts
The newest generation of ultra-low profile endografts allows for the treatment 
of AAAs in patients who were previously not candidates because of diseased and/or 
small access vessels. The Ovation Prime (Endologix, Irvine, California) stent graft 
system is delivered through a 14-Fr sheath. In the Ovation international pivotal 
trial, 40% of patients treated had access vessels smaller than 6 mm—the smallest 
access vessel was 4.7 mm in diameter—with a reported technical success rate of 
100%; [45, 46]. Other low-profile devices currently in development or with limited 
approved use in the United States are the Incraft (Cordis Corp., Bridgewater, NJ) 
13–15 Fr delivery system and the Zenith Low Profile (Cook Medical, Bloomington, 
IN) 16-Fr delivery system [47].
The AFX bifurcated unibody aortic endograft (Endologix, Irvine, California)—
FDA-approved for EVAR—has also been successful in treating TASC D AIOD 
lesions with primary and assisted primary patency rates of 91 and 97% at 1 year, 
respectively (Figure 3) [48]. Unlike traditional modular bifurcated aortic endo-
grafts with fixation points at the infrarenal proximal aortic neck, the AFX is fixed 
at the aortic bifurcation [49]. Furthermore, it is delivered through a 17-Fr ipsilateral 
and a 9-Fr contralateral sheath facilitating advancement and deployment in heavily 
calcified, small-caliber iliac arteries [49]. In a recent study, the AFX unibody stent 
was successfully used in the treatment of TASC C/D lesions in patients with con-
comitant AAA [50]. At 1-year follow-up, no adverse events were reported; however, 
two patients required stenting of their EIAs due to worsening disease [50].
The Nellix Endovascular sealing system (Endologix, Irvine, California) is an 
investigational device that has a femoral access diameter requirement of at least 
7-mm and involves injecting a biostable polyethylene glycol polymer into “endo-
bags,” which allow exclusion of the aneurysm and prevention of type 2 endoleaks 
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[51]. It has been successfully used in unilateral and bilateral common iliac artery 
occlusive disease ranging from 70% stenosis to complete occlusion [52]. In a study 
of Nellix system in five patients who had some degree of AIOD, occluded arteries 
were pretreated with balloon-expandable covered stents to create a patent conduit 
to accommodate the Nellix endograft. The aortic endograft was deployed success-
fully in 100% of cases without any endoleak at 9 months follow-up. Notably, this 
system has also been described in one case of infrarenal aortic stenosis, indicating 
that it has wider applicability in various degrees of AIOD [53, 54].
3.9 Common complications and management
The overall perioperative and long-term complication rates in patients with 
difficult EVAR access vessels have been reported to be 12 and 6%, respectively. 
Most commonly reported complication rates in the literature include 2.6–3.6% iliac 
rupture rates, 6% arterial dissections, 1.6–4% lower extremity ischemia, and 14% 
access site hematomas [10, 28, 41].
Iliac rupture from access is the leading cause of procedure-related mortality. If 
the guide wire is still in place, artery ruptures are better managed with endovascu-
lar placement of covered stents and usually do not require conversion to an open 
procedure. If a covered stent is not immediately available, an occlusive balloon 
catheter can be inserted and insufflated proximal to the rupture to achieve relative 
hemostasis without further damage at the rupture site until a stent graft or more 
definitive means of repair is delivered. In deploying covered stents for treatment of 
inadvertent arterial rupture, it is important to achieve long proximal and distal seal 
zones as the damage to the vessel is often more extensive than suggested by angiog-
raphy [14]. A 10-cm self-expanding covered stent provides adequate proximal and 
distal seal in most cases. Iliac arteries less than 5-mm in diameter are considered to 
Figure 3. 
(A) Intraoperative angiogram showing an infrarenal abdominal aortic aneurysm with concomitant severely 
symptomatic, nearly occlusive right proximal common iliac artery and high-grade stenosis of the proximal to 
mid-left common iliac artery. Note the diffusely diseased, narrow external iliac arteries along with a narrow 
distal aortic domain—all of which render deployment of a modular bifurcated device challenging and prone 
to complications including inadequate opening of the contralateral gate and iliac limb occlusions. (B) An AFX 
bifurcated unibody endograft (Endologix, Irvine, California) is preferred under these circumstances to treat 
both the AAA and the AIOD. Completion angiogram demonstrating complete exclusion of the AAA and a 
widely patent aortic endograft, CIAs, and EIAs without endoleak or kinks.
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be more prone to rupture; therefore, prophylactic adjunctive procedures should be 
considered in these patients [41]. Almost all open iliac repairs are associated with 
postoperative morbidity [55].
The most feared complication is “iliac-artery-on-a-stick” or avulsion of the 
external iliac artery due to passage of a sheath in the setting of size mismatch. In 
most cases, the damage occurs initially with introduction of the sheath, but does not 
become obvious until the sheath is removed. This complication can be suspected when 
a large sheath suddenly advances easily after initial difficulty and can be avoided by 
proceeding with prophylactic endoconduit creation. If iliac avulsion is confirmed, an 
occlusion balloon may be left in place during sheath removal for immediate control. 
Conversion to open iliac artery exposure and endovascular reconstruction are both 
practical options. Proximally, the covered stent is bridged with stents to the aortic 
endograft. Hemorrhage from the internal iliac artery can be controlled with emboliza-
tion or intentional ostial coverage. If adequate repair of rupture requires distal exten-
sion of the stent-graft well into the CFA, surgical modification and incorporation of 
the covered stent in to the common femoral artery is recommended.
In patients undergoing branched or fenestrated aortic endovascular repairs 
(FB-EVAR), hostile iliac anatomy due to calcification, stenosis, or tortuosity does 
not significantly affect the early outcome of FB-EVAR in terms of technical success 
and 30-day mortality. However, procedures performed in patients with such charac-
teristics are technically more demanding and the adverse iliac anatomy is associated 
with reduced 3-year survival [56].
4. Conclusions
Patients with coexisting aortic aneurysms and aortoiliac occlusive disease repre-
sent a challenging subset at risk for higher perioperative and long-term complications 
rates following EVAR. Nevertheless, advancing endovascular stent graft technology 
and increased surgeon familiarity with prophylactic and bail-out techniques have 
increasingly facilitated EVAR in patients traditionally deemed unsuitable candidates 
given their compromised access vessels and iliac landing zones. Preoperative plan-
ning is essential for successful delivery of these multifaceted techniques that require 
a wide range of adjunctive equipment and preparatory maneuvers to prevent life-
threatening complications. Next generation aortic stent grafts may forego the need 
for these adjunctive modalities via lower profile delivery means.
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